Related Experiment Video
Updated: Jun 9, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Tricuspid Regurgitation in a Patient with Heart Transplant: Percutaneous Management
Pabla Cataldo1, Franco Appiani2, Christian Dauvergne1
1Department of Cardiology, Instituto Nacional del Tórax, Santiago, Chile.
Abstract:
Tricuspid regurgitation (TR) is the most frequent valvular complication after heart transplantation with different clinical sequelae. In its most severe form, it can cause right heart failure with a poor long-term prognosis. Its management is complex, both medical, surgical, and percutaneous. The TricValve system, a bicaval system with two self-expanding valves (superior vena cava and inferior vena cava), dedicated to treating symptomatic IT refractory to medical therapy, is safe and effective in improving quality of life. We present the first heart transplant patient with severe symptomatic TR who underwent successful bicaval valve (TricValve) implantation.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Aortic Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management

